Laser Assisted Treatment of Fistula In Ano

Status Recruiting

Clinical Trial Summary

Randomised Controlled Trial comparing Laser assisted closure of transsphincteric fistula to the rectal advancement flap.

Clinical Trial Description

A prevalent and complex fistula type is the high transsphincteric (TS) fistula. It typically runs through the upper two-thirds of the external anal sphincter (EAS) and is, due to the high risk of fecal incontinence, not suitable for fistulotomy and sphincter sparing treatment is required. To be included in this trial the participants should have a single, continuous TS fistula of cryptoglandular origin, that is treated by loose seton drainage for at least 2 months and is mapped by MRI. Participants with IBD, hidradenitis suppurativa or a malignant fistula will be excluded. Intervention Fistula Laser Closing (FiLaCTM) (Biolitec, Germany) is an endofistular technique, using a radial-emitting laser fiber that emits laser light with a maximum penetration depth of 2 - 3 mm. It destroys both the crypt gland and the additional epithelial layer of the fistula without damaging the sphincter. The fiber is inserted until the internal opening, activated and pulled backwards slowly, allowing the laser to have its effect. The external opening is excised and the internal opening is closed with a single absorbable suture. Rectal advancement flap is currently the gold standard for sphincter sparing treatment of high transsphincteric fistulae. The fistula is cored out and an advancement flap is made of mucosa and submucosa. The opening of the fistula in the flap is excised, the residual internal opening is closed with absorbable suture and the flap is sutured below the fistula to the anoderm. The advancement flap is a difficult technique that requires a relatively large transanal dissection that results in postoperative pain and may lead to disturbances in continence. Preliminary results with the Filac technique show fistula healing rates comparable to the advancement flap. Due to its simplicity, speed and minimal invasiveness the investigators expect a benefit for the participants in terms of postoperative pain, operating time and quality of life. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05390151
Study type	Interventional
Source	University Hospital, Antwerp
Contact	Sander Van Hoof, M.D.
Phone	+3238212434
Email	sander.vanhoof@uza.be
Status	Recruiting
Phase	N/A
Start date	March 1, 2022
Completion date	March 1, 2026

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT02423330` - A Prospective Evaluation of the Strattice-LIFT to Treat Anal Fistula	Early Phase 1
Terminated	`NCT03381365` - Efficacy of an Anorectal Fistula Plug With Sealing of the Internal Opening as a Treatment for Perianal Fistula	N/A
Suspended	`NCT04660903` - Treatment of Fistula in Ano With Autologous Fatty Tissue Cells Transplantation	N/A
Recruiting	`NCT04187651` - PRP Use in Treatment of Fistula Ano	N/A
Completed	`NCT04069728` - The Impact of 3D Anal Fistula Models on Patient Understanding and Decision Making	N/A
Completed	`NCT06380036` - Two Approaches to Lower the Chances of Recurrence of Anal Fistula After Surgery	N/A
Recruiting	`NCT05039411` - Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas Patients With Crohn's Disease	Phase 1
Completed	`NCT01880398` - Management of Fistula in Ano by Kshar Sutra, Para Surgical Procedure.	N/A
Completed	`NCT03449069` - Pediatric MSC-AFP Sub-study for Crohn's Fistula	Phase 1
Completed	`NCT04588701` - Long Term Outcomes After Surgery for Anal Fistula
Recruiting	`NCT05666609` - Fistula-in-ano in Infants and Children	N/A
Completed	`NCT06212739` - Post-op Pain After Fistula Laser Closure or Ligation of the Intersphincteric Tract for Anal Fistula	N/A
Completed	`NCT01954225` - Role of Udumbara Sutra in the Management of Fistula in Ano a Rare Case Study	N/A
Completed	`NCT05223309` - High Type Fistula in Ano, Use Staged Seton, Loose Thick Sutures
Terminated	`NCT02686580` - Feasibility Study to Assess the Early Use of Porcine Cross-linked Collagen Paste in Cryptoglandular Anorectal Fistulas	Phase 3
Completed	`NCT05660876` - Fistulotomy Versus Fistulotomy With Marsupialization	N/A
Recruiting	`NCT04161469` - Laser Closure of Anal Fistula (FiLaC)	N/A
Completed	`NCT04215718` - Fistulotomy With Marsupialization Versus Fistulectomy With Wound Sutures in Simple Anal Fistula	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Laser Assisted Treatment of Fistula In Ano — LATFIA

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms